Full Library

Return to list of results

IDSA COVID-19 Guideline, Part 3: Molecular Diagnostics

RIS

Recommended format for most reference management software

BibTeX

Recommended format for BibTeX-specific software

Open in Zotero
View on zotero.org
Resource type
Web Page
Author/contributor
Title
IDSA COVID-19 Guideline, Part 3: Molecular Diagnostics
Abstract
Direct detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acids in respiratory tract specimens informs patient, healthcare institution, and public health level decision-making. IDSA has developed an evidence-based diagnostic guideline to assists clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 nucleic acid amplification tests.
URL
https://www.idsociety.org/practice-guideline/covid-19-guideline-diagnostics/
Accessed
12/2/20, 8:21 AM
Language
en
Citation
Kimberly E. Hanson et al. (n.d.). IDSA COVID-19 Guideline, Part 3: Molecular Diagnostics. Retrieved December 2, 2020, from https://www.idsociety.org/practice-guideline/covid-19-guideline-diagnostics/
GUIDELINES
ORGANISMS
Link to this record
https://transplantid.net/ANPVQZJI